1. Clonal state of human hepatocellular carcinoma and non-tumorous hepatocytes

   • Mariko Esumi
   • Yuji Tanaka
   • Toshio Shikata

   First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 1: Epidemiology and Pathology Pages: S1 - S3

2. Hepatocellular carcinoma with sarcomatous change: a special reference to the relationship with anticancer therapy

   • Masamichi Kojiro
   • Shigetaka Sugihara
   • Kazumitsu Kiyomatsu

   First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 1: Epidemiology and Pathology Pages: S4 - S8

3. Randomized controlled study of mitomycin C/carboquone/5-fluorouracil/OK-432 (MQ-F-OK) therapy and mitomycin C/5-fluorouracil/doxorubicin (FAM) therapy against advanced liver cancer

   • Yuh Sakata
   • Yoshihiko Komatsu
   • Yutaka Yoshida

   First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 2: Chemotherapy, Immunotherapy and Radiotherapy Pages: S9 - S12

4. Treatment of primary liver cancer in Singapore A review of 3200 cases seen between January 1, 1977, and July 31, 1987

   • Chong-Jin Oon
   • Abu Rauff
   • Lenny K. A. Tan

   First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 2: Chemotherapy, Immunotherapy and Radiotherapy Pages: S13 - S16

5. Cooperative study on arterial regional chemotherapy for primary liver cancer in Hokkaido

   • Mitsuo Kusano
   • Michio Mito
   • Yoichi Uekita

   First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 2: Chemotherapy, Immunotherapy and Radiotherapy Pages: S17 - S20

6. Effects of transcatheter arterial chemoembolization with oral chemotherapy on hepatic neoplasmas

   • Naoaki Hashimoto
   • Saburo Kawai
   • The National Hospitals Multicenter Study Group for Liver Cancer Treatment

   First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 2: Chemotherapy, Immunotherapy and Radiotherapy Pages: S21 - S25

7. Transcatheter arterial chemoembolization for hepatocellular carcinoma

   • Chien-Fang Yang
   • Yung-Zen Ho
   • Gran-Hum Chen

   First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 2: Chemotherapy, Immunotherapy and Radiotherapy Pages: S26 - S28

8. Studies on the chemotherapy with 5-fluorouracil in trascatheter arterial chemoembolization (TAE) treated patients with resectable or non-resectable hepatocellular carcinoma

   • Osaka Study Group on Hepatocellular Carcinoma

   First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 2: Chemotherapy, Immunotherapy and Radiotherapy Pages: S29 - S32

9. Transcatheter arterial embolization using iodized oil (lipiodol) mixed with an anticancer drug for the treatment of hepatocellular carcinoma

   • Hajime Ohishi
   • Hitoshi Yoshimura
   • Tadasu Tsujii

   First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 2: Chemotherapy, Immunotherapy and Radiotherapy Pages: S33 - S36

10. Arterial chemotherapy and transcatheter arterial embolization therapy for non-resectable hepatocellular carcinoma

    • Kenji Hirai
    • Yoshiharu Kawazoe
    • Kyuichi Tanikawa

    First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 2: Chemotherapy, Immunotherapy and Radiotherapy Pages: S37 - S41

11. Combination chemoembolization therapy for hepatocellular carcinoma: mainly, using cisplatin (CDDP)

    • Hiraku Yodono
    • Yoko Saito
    • Shoichi Takekawa

    First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 2: Chemotherapy, Immunotherapy and Radiotherapy Pages: S42 - S44

12. Treatment of hepatocellular carcinoma utilizing lymphokine-activated killer cells and interleukin-2

    • Takafumi Ichida
    • Kiyohiro Higuchi
    • Fumihiro Ichida

    First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 2: Chemotherapy, Immunotherapy and Radiotherapy Pages: S45 - S48

13. Hepatic irradiation in primary and metastatic liver cancer

    • Kazuo Hatano
    • Shuichi Mikuriya
    • Yoshihiro Hada

    First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 2: Chemotherapy, Immunotherapy and Radiotherapy Pages: S49 - S53

14. Radioiodinated fatty acid esters in the management of hepatocellular carcinoma: preliminary findings

    • Hyung Sik Yoo
    • Chan Hee Park
    • M. T. Madsen

    First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 2: Chemotherapy, Immunotherapy and Radiotherapy Pages: S54 - S58

15. Alleviation of gallbladder complications by treatment of hepatic arterial embolization with caerulein

    • Koichi Akamatsu
    • Soichiro Miyauchi
    • Ken Hamamoto

    First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 2: Chemotherapy, Immunotherapy and Radiotherapy Pages: S59 - S64

16. Effect of caerulein on abdominal pain following transcatheter hepatic arterial embolization in malignant liver cancer patients

    • Kunio Ido
    • Kyoichi Hiramatsu

    First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 2: Chemotherapy, Immunotherapy and Radiotherapy Pages: S65 - S67

17. Hepatic arterial chemotherapy for primary and metastatic liver cancers

    • William Ensminger

    First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 2: Chemotherapy, Immunotherapy and Radiotherapy Pages: S68 - S73

18. Liver resection using a water jet

    • Yoshie Une
    • Junichi Uchino
    • Fumio Sano

    First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 3: Surgery Pages: S74 - S77

19. Liver resection for hepatocellular carcinoma: results from 150 consecutive patients

    • Naofumi Nagasue
    • Hirofumi Yukaya

    First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 3: Surgery Pages: S78 - S82

20. Conditions favoring long-term survival after hepatectomy for hepatocellular carcinomas

    • Naoki Yamanaka
    • Eizo Okamoto

    First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 3: Surgery Pages: S83 - S86

21. Multimodal treatment of hepatocellular carcinoma

    • Yoshiyuki Shimamura
    • Yoshihumi Takenaka
    • Hiroshi Hasegawa

    First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 3: Surgery Pages: S87 - S89

22. Significance of transcatheter chemoembolization combined with surgical resection for hepatocellular carcinomas

    • Morito Monden
    • Jun Okamura
    • Takesada Mori

    First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 3: Surgery Pages: S90 - S95

23. Clinicopathological features of malignancy in hepatocellular carcinoma

    • Junji Tanaka
    • Takayoshi Tobe
    • Souhei Minematsu

    First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 3: Surgery Pages: S96 - S100

24. Experience with major hepatic resections for hepatocellular carcinoma

    • Chao-Long Chen
    • Kuan-Meen Fang
    • Yu-Ling Hui

    First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 3: Surgery Pages: S101 - S103

25. Experience with transplantation in the treatment of liver cancer

    • Roger L. Jenkins
    • C. Wright Pinson
    • Michael D. Stone

    First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 3: Surgery Pages: S104 - S109

26. Hepatocellular carcinoma in adenomatous hyperplasia of the liver

    • Masami Sakurai
    • Ken'ichi Wakasa
    • Jun Okamura

    First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 4: Panel Discussion Pages: S110 - S113

27. A large-scale cohort study on risk factors for primary liver cancer, with special reference to the role of cigarette smoking

    • Takeshi Hirayama

    First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 4: Panel Discussion Pages: S114 - S117

28. Current status and future aspects on treatment of liver cancer

    • Byung Soo Kim
    • Hyung Sik Yoo
    • John J. K. Loh

    First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 4: Panel Discussion Pages: S118 - S120

29. Treatment of hepatic cancer by hepatic arterial infusion chemotherapy

    • Tsuyoshi Miura

    First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 4: Panel Discussion Pages: S121 - S122

30. Hepatic artery embolization for inoperable hepatocellular carcinoma; prognosis and Risk Factors

    • Kenichi Takayasu
    • Michihiro Suzuki
    • Hiroshi Hasegawa

    First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 4: Panel Discussion Pages: S123 - S125

31. A pre-operative chemoembolization therapy using lipiodol, cisplatin and gelatin sponge for hepatocellular carcinoma

    • Shingi Imaoka
    • Yo Sasaki
    • Takeshi Iwanaga

    First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 4: Panel Discussion Pages: S126 - S128

32. Long-term prognosis of surgical patients with hepatocellular carcinoma

    • Nobuhiro Kawano
    • Yoshimichi Ohmori
    • Yasuhiko Morioka

    First International Symposium on Treatment of Liver Cancer Kobe, Japan, 15–16 November 1987 Session 4: Panel Discussion Pages: S129 - S132